Eintrag weiter verarbeiten

Beta-trace protein as a new non-invasive immunological marker for quinolinic acid-induced impaired blood-brain barrier integrity

Gespeichert in:

Veröffentlicht in: Scientific reports 7(2017) Artikel-Nummer 43642, 8 Seiten
Personen und Körperschaften: Baranyi, Andreas (VerfasserIn), März, Winfried (VerfasserIn)
Titel: Beta-trace protein as a new non-invasive immunological marker for quinolinic acid-induced impaired blood-brain barrier integrity/ Andreas Baranyi, Omid Amouzadeh-Ghadikolai, Dirk von Lewinski, Robert J. Breitenecker, Tatjana Stojakovic, Winfried März, Christoph Robier, Hans-Bernd Rothenhäusler, Harald Mangge & Andreas Meinitzer
Format: E-Book-Kapitel
Sprache: Englisch
veröffentlicht:
09 March 2017
Gesamtaufnahme: : Scientific reports, 7(2017) Artikel-Nummer 43642, 8 Seiten
, volume:7
Quelle: Verbunddaten SWB
Lizenzfreie Online-Ressourcen
LEADER 03737caa a2200529 4500
001 0-1581124600
003 DE-627
005 20220815013846.0
007 cr uuu---uuuuu
008 180919s2017 xx |||||o 00| ||eng c
024 7 |a 10.1038/srep43642  |2 doi 
035 |a (DE-627)1581124600 
035 |a (DE-576)511124600 
035 |a (DE-599)BSZ511124600 
035 |a (OCoLC)1341018840 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
100 1 |a Baranyi, Andreas  |e VerfasserIn  |0 (DE-588)116736449X  |0 (DE-627)1031032460  |0 (DE-576)511124716  |4 aut 
245 1 0 |a Beta-trace protein as a new non-invasive immunological marker for quinolinic acid-induced impaired blood-brain barrier integrity  |c Andreas Baranyi, Omid Amouzadeh-Ghadikolai, Dirk von Lewinski, Robert J. Breitenecker, Tatjana Stojakovic, Winfried März, Christoph Robier, Hans-Bernd Rothenhäusler, Harald Mangge & Andreas Meinitzer 
264 1 |c 09 March 2017 
300 |a 8 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 19.08.2018 
520 |a Quinolinic acid, a macrophage/microglia-derived excitotoxin fulfills a plethora of functions such as neurotoxin, gliotoxin, and proinflammatory mediator, and it alters the integrity and cohesion of the blood-brain barrier in several pathophysiological states. Beta-trace protein (BTP), a monomeric glycoprotein, is known to indicate cerebrospinal fluid leakage. Thus, the prior aim of this study was to investigate whether BTP might non-invasively indicate quinolinic acid-induced impaired blood-brain barrier integrity. The research hypotheses were tested in three subsamples with different states of immune activation (patients with HCV-infection and interferon-α, patients with major depression, and healthy controls). BTP has also been described as a sensitive marker in detecting impaired renal function. Thus, the renal function has been considered. Our study results revealed highest quinolinic acid and highest BTP- levels in the subsample of patients with HCV in comparison with the other subsamples with lower or no immune activation (quinolinic acid: F = 21.027, p < 0.001 [ANOVA]; BTP: F = 6.792, p < 0.01 [ANOVA]). In addition, a two-step hierarchical linear regression model showed that significant predictors of BTP levels are quinolinic acid, glomerular filtration rate and age. The neurotoxin quinolinic acid may impair blood-brain barrier integrity. BTP might be a new non-invasive biomarker to indicate quinolinic acid-induced impaired blood-brain barrier integrity. 
700 1 |a März, Winfried  |d 1958-  |e VerfasserIn  |0 (DE-588)1027603599  |0 (DE-627)729463605  |0 (DE-576)373454635  |4 aut 
773 0 8 |i Enthalten in  |t Scientific reports  |d [London] : Macmillan Publishers Limited, part of Springer Nature, 2011  |g 7(2017) Artikel-Nummer 43642, 8 Seiten  |h Online-Ressource  |w (DE-627)663366712  |w (DE-600)2615211-3  |w (DE-576)346641179  |x 2045-2322  |7 nnns 
773 1 8 |g volume:7  |g year:2017  |g extent:8 
856 4 0 |u http://dx.doi.org/10.1038/srep43642  |x Verlag  |x Resolving-System  |z kostenfrei  |3 Volltext 
856 4 0 |u https://www.nature.com/articles/srep43642  |x Verlag  |z kostenfrei  |3 Volltext 
936 u w |d 7  |j 2017  |g 8  |y 7(2017) Artikel-Nummer 43642, 8 Seiten 
951 |a AR 
856 4 0 |u http://dx.doi.org/10.1038/srep43642  |9 LFER 
852 |a LFER  |z 2018-10-10T00:00:00Z 
970 |c OD 
971 |c EBOOK 
972 |c EBOOK 
973 |c Aufsatz 
935 |a lfer 
900 |a Marz, Winfried 
900 |a März, W. 
900 |a März, Winifred 
900 |a März, Winfried Georg 
900 |a März, Winfried G. 
951 |b XA-AT 
980 |a 1581124600  |b 0  |k 1581124600  |o 511124600  |c lfer 
openURL url_ver=Z39.88-2004&ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fvufind.svn.sourceforge.net%3Agenerator&rft.title=Beta-trace+protein+as+a+new+non-invasive+immunological+marker+for+quinolinic+acid-induced+impaired+blood-brain+barrier+integrity&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Adc&rft.creator=Baranyi%2C+Andreas&rft.pub=&rft.format=Journal&rft.language=English&rft.issn=2045-2322
SOLR
_version_ 1757949970417188864
access_facet Electronic Resources
author Baranyi, Andreas, März, Winfried
author_facet Baranyi, Andreas, März, Winfried
author_role aut, aut
author_sort Baranyi, Andreas
author_variant a b ab, w m wm
callnumber-sort
collection lfer
container_reference 7(2017) Artikel-Nummer 43642, 8 Seiten
container_title Scientific reports
contents Quinolinic acid, a macrophage/microglia-derived excitotoxin fulfills a plethora of functions such as neurotoxin, gliotoxin, and proinflammatory mediator, and it alters the integrity and cohesion of the blood-brain barrier in several pathophysiological states. Beta-trace protein (BTP), a monomeric glycoprotein, is known to indicate cerebrospinal fluid leakage. Thus, the prior aim of this study was to investigate whether BTP might non-invasively indicate quinolinic acid-induced impaired blood-brain barrier integrity. The research hypotheses were tested in three subsamples with different states of immune activation (patients with HCV-infection and interferon-α, patients with major depression, and healthy controls). BTP has also been described as a sensitive marker in detecting impaired renal function. Thus, the renal function has been considered. Our study results revealed highest quinolinic acid and highest BTP- levels in the subsample of patients with HCV in comparison with the other subsamples with lower or no immune activation (quinolinic acid: F = 21.027, p < 0.001 [ANOVA]; BTP: F = 6.792, p < 0.01 [ANOVA]). In addition, a two-step hierarchical linear regression model showed that significant predictors of BTP levels are quinolinic acid, glomerular filtration rate and age. The neurotoxin quinolinic acid may impair blood-brain barrier integrity. BTP might be a new non-invasive biomarker to indicate quinolinic acid-induced impaired blood-brain barrier integrity.
ctrlnum (DE-627)1581124600, (DE-576)511124600, (DE-599)BSZ511124600, (OCoLC)1341018840
doi_str_mv 10.1038/srep43642
facet_avail Online, Free
finc_class_facet not assigned
finc_id_str 0021320280
footnote Gesehen am 19.08.2018
format ElectronicBookComponentPart
format_access_txtF_mv Article, E-Article
format_de105 Ebook
format_de14 Article, E-Article
format_de15 Article, E-Article
format_del152 Buch
format_detail_txtF_mv text-online-monograph-child
format_dezi4 e-Book
format_finc Article, E-Article
format_legacy ElectronicBookPart
format_strict_txtF_mv E-Article
geogr_code not assigned
geogr_code_person Austria
hierarchy_parent_id 0-663366712
hierarchy_parent_title Scientific reports
hierarchy_sequence 7(2017) Artikel-Nummer 43642, 8 Seiten
hierarchy_top_id 0-663366712
hierarchy_top_title Scientific reports
id 0-1581124600
illustrated Not Illustrated
imprint 09 March 2017
imprint_str_mv 09 March 2017
institution DE-D117, DE-105, LFER, DE-Ch1, DE-15, DE-14, DE-Zwi2
is_hierarchy_id 0-1581124600
is_hierarchy_title Beta-trace protein as a new non-invasive immunological marker for quinolinic acid-induced impaired blood-brain barrier integrity
isil_str_mv LFER
issn 2045-2322
kxp_id_str 1581124600
language English
last_indexed 2023-02-16T01:42:15.919Z
marc024a_ct_mv 10.1038/srep43642
match_str baranyi2017betatraceproteinasanewnoninvasiveimmunologicalmarkerforquinolinicacidinducedimpairedbloodbrainbarrierintegrity
mega_collection Verbunddaten SWB, Lizenzfreie Online-Ressourcen
misc_de105 EBOOK
multipart_link 346641179
multipart_part (346641179)7(2017) Artikel-Nummer 43642, 8 Seiten
names_id_str_mv (DE-588)116736449X, (DE-627)1031032460, (DE-576)511124716, (DE-588)1027603599, (DE-627)729463605, (DE-576)373454635
oclc_num 1341018840
physical 8
publishDate 09 March 2017
publishDateSort 2017
publishPlace
publisher
record_format marcfinc
record_id 511124600
recordtype marcfinc
rvk_facet No subject assigned
source_id 0
spelling Baranyi, Andreas VerfasserIn (DE-588)116736449X (DE-627)1031032460 (DE-576)511124716 aut, Beta-trace protein as a new non-invasive immunological marker for quinolinic acid-induced impaired blood-brain barrier integrity Andreas Baranyi, Omid Amouzadeh-Ghadikolai, Dirk von Lewinski, Robert J. Breitenecker, Tatjana Stojakovic, Winfried März, Christoph Robier, Hans-Bernd Rothenhäusler, Harald Mangge & Andreas Meinitzer, 09 March 2017, 8, Text txt rdacontent, Computermedien c rdamedia, Online-Ressource cr rdacarrier, Gesehen am 19.08.2018, Quinolinic acid, a macrophage/microglia-derived excitotoxin fulfills a plethora of functions such as neurotoxin, gliotoxin, and proinflammatory mediator, and it alters the integrity and cohesion of the blood-brain barrier in several pathophysiological states. Beta-trace protein (BTP), a monomeric glycoprotein, is known to indicate cerebrospinal fluid leakage. Thus, the prior aim of this study was to investigate whether BTP might non-invasively indicate quinolinic acid-induced impaired blood-brain barrier integrity. The research hypotheses were tested in three subsamples with different states of immune activation (patients with HCV-infection and interferon-α, patients with major depression, and healthy controls). BTP has also been described as a sensitive marker in detecting impaired renal function. Thus, the renal function has been considered. Our study results revealed highest quinolinic acid and highest BTP- levels in the subsample of patients with HCV in comparison with the other subsamples with lower or no immune activation (quinolinic acid: F = 21.027, p < 0.001 [ANOVA]; BTP: F = 6.792, p < 0.01 [ANOVA]). In addition, a two-step hierarchical linear regression model showed that significant predictors of BTP levels are quinolinic acid, glomerular filtration rate and age. The neurotoxin quinolinic acid may impair blood-brain barrier integrity. BTP might be a new non-invasive biomarker to indicate quinolinic acid-induced impaired blood-brain barrier integrity., März, Winfried 1958- VerfasserIn (DE-588)1027603599 (DE-627)729463605 (DE-576)373454635 aut, Enthalten in Scientific reports [London] : Macmillan Publishers Limited, part of Springer Nature, 2011 7(2017) Artikel-Nummer 43642, 8 Seiten Online-Ressource (DE-627)663366712 (DE-600)2615211-3 (DE-576)346641179 2045-2322 nnns, volume:7 year:2017 extent:8, http://dx.doi.org/10.1038/srep43642 Verlag Resolving-System kostenfrei Volltext, https://www.nature.com/articles/srep43642 Verlag kostenfrei Volltext, http://dx.doi.org/10.1038/srep43642 LFER, LFER 2018-10-10T00:00:00Z
spellingShingle Baranyi, Andreas, März, Winfried, Beta-trace protein as a new non-invasive immunological marker for quinolinic acid-induced impaired blood-brain barrier integrity, Quinolinic acid, a macrophage/microglia-derived excitotoxin fulfills a plethora of functions such as neurotoxin, gliotoxin, and proinflammatory mediator, and it alters the integrity and cohesion of the blood-brain barrier in several pathophysiological states. Beta-trace protein (BTP), a monomeric glycoprotein, is known to indicate cerebrospinal fluid leakage. Thus, the prior aim of this study was to investigate whether BTP might non-invasively indicate quinolinic acid-induced impaired blood-brain barrier integrity. The research hypotheses were tested in three subsamples with different states of immune activation (patients with HCV-infection and interferon-α, patients with major depression, and healthy controls). BTP has also been described as a sensitive marker in detecting impaired renal function. Thus, the renal function has been considered. Our study results revealed highest quinolinic acid and highest BTP- levels in the subsample of patients with HCV in comparison with the other subsamples with lower or no immune activation (quinolinic acid: F = 21.027, p < 0.001 [ANOVA]; BTP: F = 6.792, p < 0.01 [ANOVA]). In addition, a two-step hierarchical linear regression model showed that significant predictors of BTP levels are quinolinic acid, glomerular filtration rate and age. The neurotoxin quinolinic acid may impair blood-brain barrier integrity. BTP might be a new non-invasive biomarker to indicate quinolinic acid-induced impaired blood-brain barrier integrity.
swb_id_str 511124600
title Beta-trace protein as a new non-invasive immunological marker for quinolinic acid-induced impaired blood-brain barrier integrity
title_auth Beta-trace protein as a new non-invasive immunological marker for quinolinic acid-induced impaired blood-brain barrier integrity
title_full Beta-trace protein as a new non-invasive immunological marker for quinolinic acid-induced impaired blood-brain barrier integrity Andreas Baranyi, Omid Amouzadeh-Ghadikolai, Dirk von Lewinski, Robert J. Breitenecker, Tatjana Stojakovic, Winfried März, Christoph Robier, Hans-Bernd Rothenhäusler, Harald Mangge & Andreas Meinitzer
title_fullStr Beta-trace protein as a new non-invasive immunological marker for quinolinic acid-induced impaired blood-brain barrier integrity Andreas Baranyi, Omid Amouzadeh-Ghadikolai, Dirk von Lewinski, Robert J. Breitenecker, Tatjana Stojakovic, Winfried März, Christoph Robier, Hans-Bernd Rothenhäusler, Harald Mangge & Andreas Meinitzer
title_full_unstemmed Beta-trace protein as a new non-invasive immunological marker for quinolinic acid-induced impaired blood-brain barrier integrity Andreas Baranyi, Omid Amouzadeh-Ghadikolai, Dirk von Lewinski, Robert J. Breitenecker, Tatjana Stojakovic, Winfried März, Christoph Robier, Hans-Bernd Rothenhäusler, Harald Mangge & Andreas Meinitzer
title_in_hierarchy Beta-trace protein as a new non-invasive immunological marker for quinolinic acid-induced impaired blood-brain barrier integrity / Andreas Baranyi, Omid Amouzadeh-Ghadikolai, Dirk von Lewinski, Robert J. Breitenecker, Tatjana Stojakovic, Winfried März, Christoph Robier, Hans-Bernd Rothenhäusler, Harald Mangge & Andreas Meinitzer,
title_short Beta-trace protein as a new non-invasive immunological marker for quinolinic acid-induced impaired blood-brain barrier integrity
title_sort beta trace protein as a new non invasive immunological marker for quinolinic acid induced impaired blood brain barrier integrity
url http://dx.doi.org/10.1038/srep43642, https://www.nature.com/articles/srep43642